Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics
Aitechpark18 Mar, 2021Technology
Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods, today announced it has signed a non-exclusive license agreement with Quest Diagnostics (NYSE: DGX), the world leader in diagnostic information services, for Zora?s patented ceramide-analysis technology.
Related Bookmarks
- Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics
- Nexign & MegaFon Finish Project Facilitating Digital Transformation
- Kaye Launches LabWatch� IoT � A Cloud-Based Monitoring System
- Avast CISO Jaya Baloo to Interview Ethical Hackers at SXSW 2021
- BreakBot: The Google Calendar Add-On That Knows You Deserve A Break
- What is a Common Reason To Hire an SEO Service?
- Find Reliable HR Software for Sale in Quebec
- Buy Online Amazing Payroll Management Software in Canada
- Best Accounting Firm Management Software for Universities in Canada
- What Are Retrogen�s Covid-19 Test Benefits
Recent Profiles
Jaruk Com
Ceotrananquocfzaan
Champions Garage Door Service
A2z Plumbing
Kèo Nhà Cái - Bảng Tỷ Lệ Kèo Bóng Đá
Sophia Smith
Kmtconstructionllc
Fatima
Legacyofdeades
Shree Shankar Band